The Washington University Medical Scientist Training Program at Washington University in St. Louis was established in 1969, and has been continuously funded by the NIH since 1970. It has trained 658 MD-PhDs, more than any program in the nation. As it has been since the program's founding, our primary goal is to identify, train, and mentor a diverse group of women and men who will become leaders biomedical research, patient care, and medical education. To that end, we have designed a flexible, individualized training pathway that emphasizes the integration of clinical and research training. The University's substantial commitment to the program is evident not only in providing 68% ($8.6 million in FY2018) of the total MSTP budget, but also in tailoring the curriculum and policies to accommodate the unique requirements of MD-PhD training. Appointments to this T32 are typically made for the first 3 years of training. We are able to leverage each of the grant?s 44 training slots by a factor of 4.4 through university and other funds, which allows us to support a current population of 192 students. To select individuals to train in the program, we focus primarily on academic achievement, research experience, and a commitment to a research career. Students typically train in the Division of Biology and Biomedical Sciences, a trans-university consortium of 11 doctoral programs, but a significant number train in other academic units, including Biomedical Engineering. The 156 training faculty for this proposal are out of a total population in these academic units of over 570 tenure-track faculty. Policies are in place to select faculty for participation in graduate training, and training faculty are reviewed every 5 years. Our program enjoys strong interactions with other programs at Washington University for training of physician-scientists after they receive their doctorates, i.e., Physician-Scientist Training Programs (PSTPs) in our clinical residency and fellowship programs. Student attrition is low and has declined significantly over the past 10 years. Time to degree has stabilized at 8.0 years, and is lower than the national average. Outcomes data shows that 78% of those that have completed postgraduate training are employed by academic institutions, research institutes, federal agencies, and biotech or pharmaceutical firms. Many have research support from the NIH or other sources, and some have leadership roles in other MD-PhD programs. While our program has had a long history of success, we are cognizant of the future challenges facing our trainees to achieve success in careers as physician-scientists involved in basic and translational research. To help them reach the highest levels of success, our goals for the next 5 years include: 1) Providing our trainees with academic programs that integrate basic science with clinical medicine; 2) Providing our trainees with a new career mentorship program that features successful physician-scientists; 3) Build on existing programs to enhance camaraderie and instill confidence that the physician-scientist pathway is viable and worthwhile; 4) Working with our PSTP colleagues to further enhance the likelihood of success of our students; 5) Working with our institutional stakeholders to reduce time to degree without sacrificing necessary rigor, and 6) Building on our recent success in recruiting a diverse cohort of individuals who will be well trained to be leaders in the discovery and application of ground-breaking research and innovative patient care.

Public Health Relevance

The rapid advances in biomedical research in recent decades has resulted in a critical need for physicians who are well-trained investigators to work at the intersection of clinical medicine and laboratory science to develop innovative approaches for the diagnosis and treatment of disability and disease. The goal of the Medical Scientist Training Program at Washington University in St. Louis is to identify, train, and mentor a diverse group of outstanding scholars to become the future leaders in biomedical research, patient care and academic medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007200-46
Application #
9791625
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
1975-07-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
46
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ligon, Marianne M; Mysorekar, Indira U (2018) Trans-mission control in the urinary tract: Local cytokine regulation of monocyte proliferation to combat infection. J Leukoc Biol 103:5-7
Barnette, Dustyn A; Davis, Mary A; Dang, Na L et al. (2018) Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approaches. Biochem Pharmacol 156:10-21
Klein, Roger D; Shu, Qin; Cusumano, Zachary T et al. (2018) Structure-Function Analysis of the Curli Accessory Protein CsgE Defines Surfaces Essential for Coordinating Amyloid Fiber Formation. MBio 9:
Lin, Joseph B; Sene, Abdoulaye; Wiley, Luke A et al. (2018) WNT7A/B promote choroidal neovascularization. Exp Eye Res 174:107-112
Wang, Zhuo A; Li, Lucy X; Doering, Tamara L (2018) Unraveling synthesis of the cryptococcal cell wall and capsule. Glycobiology 28:719-730
Li, Lucy X; Rautengarten, Carsten; Heazlewood, Joshua L et al. (2018) UDP-Glucuronic Acid Transport Is Required for Virulence of Cryptococcus neoformans. MBio 9:
Ban, Norimitsu; Lee, Tae Jun; Sene, Abdoulaye et al. (2018) Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration. J Lipid Res 59:1414-1423
Stopschinski, Barbara E; Holmes, Brandon B; Miller, Gregory M et al. (2018) Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus ?-synuclein and ?-amyloid aggregates. J Biol Chem 293:10826-10840
Verbaro, Daniel J; Sakurai, Nagisa; Kim, Byungil et al. (2018) Cutting Edge: The Histone Methyltransferase G9a Is Required for Silencing of Helper T Lineage-Associated Genes in Proliferating CD8 T Cells. J Immunol 200:3891-3896
Grither, Whitney R; Longmore, Gregory D (2018) Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain. Proc Natl Acad Sci U S A 115:E7786-E7794

Showing the most recent 10 out of 387 publications